Mark Corrigan's Net Worth
$11.3 Million
Who is Mark Corrigan?
Mark Corrigan has an estimated net worth of $11.3 Million. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, CoLucid Pharmaceuticals, Inc., Nabriva Therapeutics plc, NOVELION THERAPEUTICS INC., Wave Life Sciences Ltd., TREVENA INC, CUBIST PHARMACEUTICALS INC, EPIRUS Biopharmaceuticals, Inc., AVANIR PHARMACEUTICALS, INC., and SEPRACOR INC /DE/.
SEC CIK
Mark Corrigan's CIK is 0001250661
Past Insider Trading and Trends
2004 was Mark Corrigan's most active year for acquiring shares with 13 total transactions. Mark Corrigan's most active month to acquire stocks was the month of May. 2007 was Mark Corrigan's most active year for disposing of shares, totalling 72 transactions. Mark Corrigan's most active month to dispose stocks was the month of May. 2005 saw Mark Corrigan paying a total of $9,017,600.00 for 240,000 shares, this is the most they've acquired in one year. In 2007 Mark Corrigan cashed out on 351,382 shares for a total of $11,528,832.79, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nabriva Therapeutics Plc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
| No matching records found | |||||||||
CoLucid Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nabriva Therapeutics plc (NBRVF) Snapshot price: $0.0002
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -58.84% | -10.30K |
$0.19 | -$1,956.43 | 7.2K |
Aug 2
| |||
Form 4
|
∞
| 17.5K |
—
|
—
| 17.5K |
Jul 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVELION THERAPEUTICS INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Wave Life Sciences Ltd. (WVE) Snapshot price: $4.001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||